7 results
Barrett's Esophagus

Risk Factors, Screening, Progression to Cancer, and Monitoring

#Barretts #Esophagus #RiskFactors #Screening #Progression #Monitoring #Management #PrimaryCare
Risk Factors, Screening ... to Cancer, and Monitoring ... #RiskFactors #Screening ... #Management #PrimaryCare ... #surveillance #indications
Monitoring people with cystic fibrosis #Screening #Management #Peds #PrimaryCare #CysticFibrosis #Screening #Annual #NICE #BMJ
Monitoring people ... #Management #Peds ... #PrimaryCare #CysticFibrosis ... #Screening #Annual ... #NICE #BMJ
Supporting children born early #Management #Screening #PrimaryCare #Peds #Preterm #Premature #Surveillance #Monitoring #NICE #BMJ
children born early #Management ... #Screening #PrimaryCare ... #Surveillance #Monitoring ... #NICE #BMJ
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... optimal TTR (time in therapeutic ... #management #algorithm ... #table #pharmacotherapy ... #decisionaid #cardiology
Ambulatory devices for electrocardiogram (ECG) monitoring #Management #PrimaryCare #Cardiology #Palpitations #Indications #Holter #LoopRecorder #ImplantableLoopRecorder #BMJ
electrocardiogram (ECG) monitoring ... #Management #PrimaryCare ... #Cardiology #Palpitations ... #Indications #Holter
Gastroesophageal Reflux Disease (GERD) - Summary

GERD: Diagnosis
• Heartburn (substernal burning sensation) and acid regurgitation
• Chest pain
Extraesophageal
: Testing EGD indications ... Vomiting • Anemia Therapeutic ... when EGD and pH monitoring ... Weight loss Screening ... Disease #diagnosis #management
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
for frequency of monitoring ... G2: Abnormal screening ... requiring intravenous medications ... ICI under close monitoring ... Cardiotoxicity #cardiology